# Oxybutynin

## Oxbu 5mg extended-release

| TAH Drug Code      | [OOXB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OOXB)                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Indicated for the treatment of overactive bladder with symptoms of urgency， frequency， or urge incontinence.                                                                                                                                                                                                  |
| Dosing             | Initially， 5 mg once daily increased by 5 mg every week if necessary to the maximum 30 mg daily.                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                   |
| Contraindications  | Patients with urinary retention， gastric retention， other severe conditions of reduced gastrointestinal motility， uncontrolled narrow-angle glaucoma， or those at risk of developing these conditions. Patients known to be hypersensitive to the active ingredient or any other component of this product. |
| Adverse Effects    | Dry mouth， blurred vision， tachycardia， dizziness， impotence; allergic reactions.                                                                                                                                                                                                                           |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/oxybutynin-drug-information)                                                                                                                                                                                                                                       |

